Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09QLR
|
||||
| Former ID |
DIB012446
|
||||
| Drug Name |
Dibenzothiazepines
|
||||
| Synonyms |
Cannabinoid CB1 inverse agonists (CNS disorder); Cannabinoid CB1 inverse agonists (CNS disorder), ACADIA; CB1 inverse agonists (obesity, substance abuse), ACADIA
|
||||
| Indication | Drug abuse [ICD9: 303-304; ICD10:F10-F19] | Investigative | [552047] | ||
| Company |
ACADIA Pharmaceuticals Inc
|
||||
| Canonical SMILES |
c1c(cc(c(c1)F)Cl)C1=Nc2cc(ccc2Sc2c1cccc2)C(=O)NCCCC
|
||||
| Target and Pathway | |||||
| Target(s) | Cannabinoid receptor 1 | Target Info | Agonist | [543877] | |
| PANTHER Pathway | Endogenous cannabinoid signaling | ||||
| Pathway Interaction Database | N-cadherin signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.